ArticleNature communications2022

Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.

Yiwu Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.